BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang Y, Song X, Li Y, Su P, Han D, Ma T, Guo R, Chen B, Zhao W, Sang Y, Zhang N, Li X, Zhang H, Liu Y, Duan Y, Wang L, Yang Q. circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer. Oncogene 2019;38:6850-66. [PMID: 31406252 DOI: 10.1038/s41388-019-0926-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu J, Sun S, Mao W, Xu B, Chen M. Identification of Enzalutamide Resistance-Related circRNA-miRNA-mRNA Regulatory Networks in Patients with Prostate Cancer. Onco Targets Ther 2021;14:3833-48. [PMID: 34188491 DOI: 10.2147/OTT.S309917] [Reference Citation Analysis]
2 Wei W, Ji L, Duan W, Zhu J. CircSAMD4A contributes to cell doxorubicin resistance in osteosarcoma by regulating the miR-218-5p/KLF8 axis. Open Life Sci 2020;15:848-59. [PMID: 33817271 DOI: 10.1515/biol-2020-0079] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Xie F, Xiong Y, Yan J, Wang L, Yan W. Circular RNA circ_0048764 promotes the development of breast cancer by regulating microRNA-1296-5p/tripartite motif containing 14 axis. Bioengineered 2021. [PMID: 34787066 DOI: 10.1080/21655979.2021.1995990] [Reference Citation Analysis]
4 Xu T, Wang M, Jiang L, Ma L, Wan L, Chen Q, Wei C, Wang Z. CircRNAs in anticancer drug resistance: recent advances and future potential. Mol Cancer 2020;19:127. [PMID: 32799866 DOI: 10.1186/s12943-020-01240-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
5 Mou Y, Sun Q. The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 (laminin subunit gamma 1). Bioengineered 2022;13:746-58. [PMID: 34859735 DOI: 10.1080/21655979.2021.2012628] [Reference Citation Analysis]
6 Hu Y, Song Q, Zhao J, Ruan J, He F, Yang X, Yu X. Identification of plasma hsa_circ_0008673 expression as a potential biomarker and tumor regulator of breast cancer. J Clin Lab Anal 2020;34:e23393. [PMID: 32808350 DOI: 10.1002/jcla.23393] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Ji Y, Liu J, Zhu W, Ji J. circ_0002060 Enhances Doxorubicin Resistance in Osteosarcoma by Regulating the miR-198/ABCB1 Axis. Cancer Biother Radiopharm 2020. [PMID: 33351694 DOI: 10.1089/cbr.2020.4240] [Reference Citation Analysis]
8 Zhang C, Liu P, Huang J, Liao Y, Pan C, Liu J, Du Q, Liu T, Shang C, Ooi S, Chen R, Xia M, Jiang H, Xu M, Zou Q, Zhou Y, Huang H, Pan Y, Yuan L, Wang W, Yao S. Circular RNA hsa_circ_0043280 inhibits cervical cancer tumor growth and metastasis via miR-203a-3p/PAQR3 axis. Cell Death Dis 2021;12:888. [PMID: 34588429 DOI: 10.1038/s41419-021-04193-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Peng W, Li JD, Zeng JJ, Zou XP, Tang D, Tang W, Rong MH, Li Y, Dai WB, Tang ZQ, Feng ZB, Chen G. Clinical value and potential mechanisms of COL8A1 upregulation in breast cancer: a comprehensive analysis. Cancer Cell Int 2020;20:392. [PMID: 32818022 DOI: 10.1186/s12935-020-01465-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Bai Y, Li Y, Bai J, Zhang Y. Hsa_circ_0004674 promotes osteosarcoma doxorubicin resistance by regulating the miR-342-3p/FBN1 axis. J Orthop Surg Res 2021;16:510. [PMID: 34407841 DOI: 10.1186/s13018-021-02631-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wang J, Zhang Y, Liu L, Yang T, Song J. Circular RNAs: new biomarkers of chemoresistance in cancer. Cancer Biol Med 2021:j. [PMID: 33738995 DOI: 10.20892/j.issn.2095-3941.2020.0312] [Reference Citation Analysis]
12 Wang Q, Liang D, Shen P, Yu Y, Yan Y, You W. Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348/ATG7 axis. Transl Oncol 2021;14:101045. [PMID: 34023560 DOI: 10.1016/j.tranon.2021.101045] [Reference Citation Analysis]
13 Lyu L, Zhang S, Deng Y, Wang M, Deng X, Yang S, Wu Y, Dai Z. Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer. J Hematol Oncol 2021;14:41. [PMID: 33676555 DOI: 10.1186/s13045-021-01052-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Garrido-Cano I, Pattanayak B, Adam-Artigues A, Lameirinhas A, Torres-Ruiz S, Tormo E, Cervera R, Eroles P. MicroRNAs as a clue to overcome breast cancer treatment resistance. Cancer Metastasis Rev 2021. [PMID: 34524579 DOI: 10.1007/s10555-021-09992-0] [Reference Citation Analysis]
15 De Palma FDE, Salvatore F, Pol JG, Kroemer G, Maiuri MC. Circular RNAs as Potential Biomarkers in Breast Cancer. Biomedicines 2022;10:725. [PMID: 35327527 DOI: 10.3390/biomedicines10030725] [Reference Citation Analysis]
16 Dou D, Ren X, Han M, Xu X, Ge X, Gu Y, Wang X, Zhao S. CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis. Cancer Cell Int 2020;20:454. [PMID: 32944002 DOI: 10.1186/s12935-020-01547-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
17 Yu J, Li F, Li Y, Li Z, Jia G, Ding B, Zhou Y. The effects of hsa_circ_0000517/miR-326 axis on the progression of breast cancer cells and the prediction of miR-326 downstream targets in breast cancer. Pathol Res Pract 2021;227:153638. [PMID: 34619576 DOI: 10.1016/j.prp.2021.153638] [Reference Citation Analysis]
18 Jiang J, Lin H, Shi S, Hong Y, Bai X, Cao X. Hsa_circRNA_0000518 facilitates breast cancer development via regulation of the miR-326/FGFR1 axis. Thorac Cancer 2020;11:3181-92. [PMID: 33000910 DOI: 10.1111/1759-7714.13641] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Ma S, Kong S, Wang F, Ju S. CircRNAs: biogenesis, functions, and role in drug-resistant Tumours. Mol Cancer 2020;19:119. [PMID: 32758239 DOI: 10.1186/s12943-020-01231-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
20 Bi Y, Zeng DX, Ye W, Xiao M, Yang QL, Ling Y. LncRNA PVT1 promotes cells proliferation via PI3K–AKT–mTOR Pathway in gastrointestinal stromal tumor. All Life 2021;14:136-46. [DOI: 10.1080/26895293.2021.1889685] [Reference Citation Analysis]
21 Wang H, Shan S, Wang H, Wang X. CircATXN7 contributes to the progression and doxorubicin resistance of breast cancer via modulating miR-149-5p/HOXA11 pathway. Anticancer Drugs 2022;33:e700-10. [PMID: 34845164 DOI: 10.1097/CAD.0000000000001243] [Reference Citation Analysis]
22 Yu L, Shi Q, Jin Y, Liu Z, Li J, Sun W. Blockage of AMPK-ULK1 pathway mediated autophagy promotes cell apoptosis to increase doxorubicin sensitivity in breast cancer (BC) cells: an in vitro study. BMC Cancer 2021;21:195. [PMID: 33632157 DOI: 10.1186/s12885-021-07901-w] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
23 Wen C, Xu G, He S, Huang Y, Shi J, Wu L, Zhou H. Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-small Cell Lung Cancer Cell Lines. J Cancer 2020;11:3816-26. [PMID: 32328186 DOI: 10.7150/jca.39783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
24 Huang L, Ma J, Cui M. Circular RNA hsa_circ_0001598 promotes programmed death-ligand-1-mediated immune escape and trastuzumab resistance via sponging miR-1184 in breast cancer cells. Immunol Res 2021;69:558-67. [PMID: 34559381 DOI: 10.1007/s12026-021-09237-w] [Reference Citation Analysis]
25 Li J, Qin X, Wu R, Wan L, Zhang L, Liu R. Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/FOXO3/ABCB1 axis. J Cell Mol Med 2020;24:5152-61. [PMID: 32222024 DOI: 10.1111/jcmm.15162] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
26 Wang Y, Zheng F, Wang Z, Lu J, Zhang H. Circular RNA circ-SLC7A6 acts as a tumor suppressor in non-small cell lung cancer through abundantly sponging miR-21. Cell Cycle 2020;19:2235-46. [PMID: 32794418 DOI: 10.1080/15384101.2020.1806449] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Chen B, Sang Y, Song X, Zhang D, Wang L, Zhao W, Liang Y, Zhang N, Yang Q. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28. Theranostics 2021;11:3932-47. [PMID: 33664871 DOI: 10.7150/thno.53412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Liu Y, Yang C, Cao C, Li Q, Jin X, Shi H. Hsa_circ_RNA_0011780 Represses the Proliferation and Metastasis of Non-Small Cell Lung Cancer by Decreasing FBXW7 via Targeting miR-544a. Onco Targets Ther 2020;13:745-55. [PMID: 32158226 DOI: 10.2147/OTT.S236162] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
29 Zhu M, Wang F, Mi H, Li L, Wang J, Han M, Gu Y. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells. Cell Cycle 2020;19:3277-88. [PMID: 33121324 DOI: 10.1080/15384101.2020.1839700] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Huang J, Yu S, Ding L, Ma L, Chen H, Zhou H, Zou Y, Yu M, Lin J, Cui Q. The Dual Role of Circular RNAs as miRNA Sponges in Breast Cancer and Colon Cancer. Biomedicines 2021;9:1590. [PMID: 34829818 DOI: 10.3390/biomedicines9111590] [Reference Citation Analysis]
31 Chen S, Liu H, Li Z, Tang J, Huang B, Zhi F, Zhao X. Epithelial PBLD attenuates intestinal inflammatory response and improves intestinal barrier function by inhibiting NF-κB signaling. Cell Death Dis 2021;12:563. [PMID: 34059646 DOI: 10.1038/s41419-021-03843-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Beilerli A, Gareev I, Beylerli O, Yang G, Pavlov V, Aliev G, Ahmad A. Circular RNAs as biomarkers and therapeutic targets in cancer. Semin Cancer Biol 2021:S1044-579X(21)00004-3. [PMID: 33434640 DOI: 10.1016/j.semcancer.2020.12.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
33 Solé C, Lawrie CH. Circular RNAs and cancer: Opportunities and challenges. Adv Clin Chem 2020;99:87-146. [PMID: 32951640 DOI: 10.1016/bs.acc.2020.02.008] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
34 Hsiang YP, Wang YT, Huang KS, Huang TY, Tai MH, Lin YM, Yang CH, Shaw JF. Facile production of chlorophyllides using recombinant CrCLH1 and their cytotoxicity towards multidrug resistant breast cancer cell lines. PLoS One 2021;16:e0250565. [PMID: 33930043 DOI: 10.1371/journal.pone.0250565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Fang J, Ji WH, Wang FZ, Xie TM, Wang L, Fu ZF, Wang Z, Yan FQ, Shen QL, Ye ZM. Circular RNA hsa_circ_0000700 promotes cell proliferation and migration in Esophageal Squamous Cell Carcinoma by sponging miR-1229. J Cancer 2021;12:2610-23. [PMID: 33854621 DOI: 10.7150/jca.47112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Zhang X, Xie K, Zhou H, Wu Y, Li C, Liu Y, Liu Z, Xu Q, Liu S, Xiao D, Tao Y. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance. Mol Cancer 2020;19:47. [PMID: 32122355 DOI: 10.1186/s12943-020-01171-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 14.5] [Reference Citation Analysis]
37 Yao Y, Li X, Cheng L, Wu X, Wu B. Circular RNA FAT atypical cadherin 1 (circFAT1)/microRNA-525-5p/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway. Bioengineered 2021;12:4032-43. [PMID: 34288822 DOI: 10.1080/21655979.2021.1951929] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
38 Xu J, Chen X, Sun Y, Shi Y, Teng F, Lv M, Liu C, Jia X. The Regulation Network and Clinical Significance of Circular RNAs in Breast Cancer. Front Oncol 2021;11:691317. [PMID: 34307155 DOI: 10.3389/fonc.2021.691317] [Reference Citation Analysis]
39 Li F, Yang Q, He AT, Yang BB. Circular RNAs in cancer: limitations in functional studies and diagnostic potential. Semin Cancer Biol 2020:S1044-579X(20)30207-8. [PMID: 33035655 DOI: 10.1016/j.semcancer.2020.10.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
40 Ma X, Ying Y, Sun J, Xie H, Li J, He L, Wang W, Chen S, Shen H, Yi J, Luo J, Wang X, Zheng X, Liu B, Xie L. circKDM4C enhances bladder cancer invasion and metastasis through miR-200bc-3p/ZEB1 axis. Cell Death Discov 2021;7:365. [PMID: 34811353 DOI: 10.1038/s41420-021-00712-9] [Reference Citation Analysis]
41 Qiu P, Bi J, Liu J, Lai C, Li X. Long non-coding RNA LINC01004 promotes malignant behaviors of pituitary adenoma via miR-323a-3p/136-5p/RCN2 axis. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153884] [Reference Citation Analysis]
42 Tang L, Jiang B, Zhu H, Gao T, Zhou Y, Gong F, He R, Xie L, Li Y. The Biogenesis and Functions of circRNAs and Their Roles in Breast Cancer. Front Oncol 2021;11:605988. [PMID: 33718157 DOI: 10.3389/fonc.2021.605988] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Song H, Liu D, Dong S, Zeng L, Wu Z, Zhao P, Zhang L, Chen ZS, Zou C. Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications. Signal Transduct Target Ther 2020;5:193. [PMID: 32900991 DOI: 10.1038/s41392-020-00300-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
44 Dong LH, Huang JJ, Zu P, Liu J, Gao X, Du JW, Li YF. CircKDM4C upregulates P53 by sponging hsa-let-7b-5p to induce ferroptosis in acute myeloid leukemia. Environ Toxicol 2021;36:1288-302. [PMID: 33733556 DOI: 10.1002/tox.23126] [Reference Citation Analysis]
45 Papatsirou M, Artemaki PI, Scorilas A, Kontos CK. The role of circular RNAs in therapy resistance of patients with solid tumors. Per Med 2020;17:469-90. [PMID: 33052780 DOI: 10.2217/pme-2020-0103] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
46 He X, Xu T, Hu W, Tan Y, Wang D, Wang Y, Zhao C, Yi Y, Xiong M, Lv W, Wu M, Li X, Wu Y, Zhang Q. Circular RNAs: Their Role in the Pathogenesis and Orchestration of Breast Cancer. Front Cell Dev Biol 2021;9:647736. [PMID: 33777954 DOI: 10.3389/fcell.2021.647736] [Reference Citation Analysis]
47 Zhong JX, Kong YY, Luo RG, Xia GJ, He WX, Chen XZ, Tan WW, Chen QJ, Huang YY, Guan YX. Circular RNA circ-ERBB2 promotes HER2-positive breast cancer progression and metastasis via sponging miR-136-5p and miR-198. J Transl Med 2021;19:455. [PMID: 34732216 DOI: 10.1186/s12967-021-03114-8] [Reference Citation Analysis]
48 Zhao CX, Yan ZX, Wen JJ, Fu D, Xu PP, Wang L, Cheng S, Hu JD, Zhao WL. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis. Mol Cancer 2021;20:153. [PMID: 34852843 DOI: 10.1186/s12943-021-01458-9] [Reference Citation Analysis]
49 Wang Y, Wang H, Zhang J, Chu Z, Liu P, Zhang X, Li C, Gu X. Circ_0007031 Serves as a Sponge of miR-760 to Regulate the Growth and Chemoradiotherapy Resistance of Colorectal Cancer via Regulating DCP1A. Cancer Manag Res 2020;12:8465-79. [PMID: 32982440 DOI: 10.2147/CMAR.S254815] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
50 Xia M, Zu X, Chen Z, Wen G, Zhong J. Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance. Cancer Lett 2021;523:100-10. [PMID: 34601022 DOI: 10.1016/j.canlet.2021.09.038] [Reference Citation Analysis]
51 Meng L, Chang S, Sang Y, Ding P, Wang L, Nan X, Xu R, Liu F, Gu L, Zheng Y, Li Z, Sang M. Circular RNA circCCDC85A inhibits breast cancer progression via acting as a miR-550a-5p sponge to enhance MOB1A expression. Breast Cancer Res 2022;24:1. [PMID: 34983617 DOI: 10.1186/s13058-021-01497-6] [Reference Citation Analysis]
52 Cheng D, Wang J, Dong Z, Li X. Cancer-related circular RNA: diverse biological functions. Cancer Cell Int 2021;21:11. [PMID: 33407501 DOI: 10.1186/s12935-020-01703-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
53 Li H, Li Q, He S. Hsa_circ_0025202 suppresses cell tumorigenesis and tamoxifen resistance via miR-197-3p/HIPK3 axis in breast cancer. World J Surg Oncol 2021;19:39. [PMID: 33536026 DOI: 10.1186/s12957-021-02149-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
54 Wang S, Qian L, Cao T, Xu L, Jin Y, Hu H, Fu Q, Li Q, Wang Y, Wang J, Xia Y, Huang X. Advances in the Study of CircRNAs in Tumor Drug Resistance. Front Oncol 2022;12:868363. [DOI: 10.3389/fonc.2022.868363] [Reference Citation Analysis]
55 Hao J, Du X, Lv F, Shi Q. Knockdown of circ_0006528 Suppresses Cell Proliferation, Migration, Invasion, and Adriamycin Chemoresistance via Regulating the miR-1236-3p/CHD4 Axis in Breast Cancer. J Surg Res 2021;260:104-15. [PMID: 33333383 DOI: 10.1016/j.jss.2020.10.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
56 Wang X, Xue B, Zhang Y, Guo G, Duan X, Dou D. Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer. Cell Death Dis 2021;12:412. [PMID: 33875646 DOI: 10.1038/s41419-021-03684-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Zang H, Li Y, Zhang X, Huang G. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p. Thorac Cancer 2020;11:1891-903. [PMID: 32445273 DOI: 10.1111/1759-7714.13475] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
58 Wm Nor WMFSB, Chung I, Said NABM. MicroRNA-548m Suppresses Cell Migration and Invasion by Targeting Aryl Hydrocarbon Receptor in Breast Cancer Cells. Oncol Res 2021;28:615-29. [PMID: 33109304 DOI: 10.3727/096504020X16037933185170] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Gong L, Zhou X, Sun J. Circular RNAs Interaction with MiRNAs: Emerging Roles in Breast Cancer. Int J Med Sci 2021;18:3182-96. [PMID: 34400888 DOI: 10.7150/ijms.62219] [Reference Citation Analysis]
60 Yin H, Cui X. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway. Cancer Biother Radiopharm 2021;36:556-67. [PMID: 32833501 DOI: 10.1089/cbr.2020.3575] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
61 Wang W, Ren P, Ren F, Huang M, Cheng X. Circ_0000526 Blocks the Progression of Breast Cancer by Sponging miR-492. Cancer Biotherapy and Radiopharmaceuticals 2021;36:467-76. [DOI: 10.1089/cbr.2019.3513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Guo XY, Liu TT, Zhu WJ, Liu HT, Zhang GH, Song L, Zhao RN, Chen X, Gao P. CircKDM4B suppresses breast cancer progression via the miR-675/NEDD4L axis. Oncogene 2022. [PMID: 35145234 DOI: 10.1038/s41388-022-02232-x] [Reference Citation Analysis]
63 Zhang Z, Hu H, Li Q, Yi F, Liu Y. A Novel Circular RNA circPTCD3 Promotes Breast Cancer Progression Through Sponging miR-198. Cancer Manag Res 2021;13:8435-43. [PMID: 34785951 DOI: 10.2147/CMAR.S256091] [Reference Citation Analysis]
64 Ashrafizadeh M, Zarrabi A, Hashemi F, Zabolian A, Saleki H, Bagherian M, Azami N, Bejandi AK, Hushmandi K, Ang HL, Makvandi P, Khan H, Kumar AP. Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity. Pharmaceutics 2020;12:E1084. [PMID: 33187385 DOI: 10.3390/pharmaceutics12111084] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
65 Chen L, Zhu X, Han B, Ji L, Yao L, Wang Z. High Expression of microRNA-223 Indicates a Good Prognosis in Triple-Negative Breast Cancer. Front Oncol 2021;11:630432. [PMID: 33928027 DOI: 10.3389/fonc.2021.630432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Zangouei AS, Alimardani M, Moghbeli M. MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells. Cancer Cell Int 2021;21:213. [PMID: 33858435 DOI: 10.1186/s12935-021-01873-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Cui C, Yang J, Li X, Liu D, Fu L, Wang X. Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance. Mol Cancer 2020;19:58. [PMID: 32171304 DOI: 10.1186/s12943-020-01180-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
68 Moldovan LI, Hansen TB, Venø MT, Okholm TLH, Andersen TL, Hager H, Iversen L, Kjems J, Johansen C, Kristensen LS. High-throughput RNA sequencing from paired lesional- and non-lesional skin reveals major alterations in the psoriasis circRNAome. BMC Med Genomics 2019;12:174. [PMID: 31775754 DOI: 10.1186/s12920-019-0616-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
69 Liu D, Fang L. Current research on circular RNAs and their potential clinical implications in breast cancer. Cancer Biol Med 2021:j. [PMID: 34018386 DOI: 10.20892/j.issn.2095-3941.2020.0275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Zhang M, Bai X, Zeng X, Liu J, Liu F, Zhang Z. circRNA-miRNA-mRNA in breast cancer. Clin Chim Acta 2021;523:120-30. [PMID: 34537217 DOI: 10.1016/j.cca.2021.09.013] [Reference Citation Analysis]
71 Ghafouri-Fard S, Hussen BM, Taheri M, Ayatollahi SA. Emerging role of circular RNAs in breast cancer. Pathol Res Pract 2021;223:153496. [PMID: 34052769 DOI: 10.1016/j.prp.2021.153496] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Sarkar D, Diermeier SD. Circular RNAs: Potential Applications as Therapeutic Targets and Biomarkers in Breast Cancer. Noncoding RNA 2021;7:2. [PMID: 33466455 DOI: 10.3390/ncrna7010002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]